Record Revenue Growth
Paysign reported record revenue of $19.1 million for Q2 2025, a 33% increase compared to Q2 2024, with gross margins improving by 870 basis points to 61.6%.
Significant Growth in Patient Affordability Business
The patient affordability business saw a 190% year-over-year revenue growth to $7.75 million, with revenue per program rising over 83%.
Expansion of Plasma Centers
Paysign onboarded 123 transitioning plasma centers late in the quarter, increasing their market share to approximately 50%.
Introduction of New Software Solutions
Paysign introduced a Software-as-a-Service engagement platform, including a donor app and plasma-specific CRM, receiving positive feedback from the industry.